LibreLink is indicated for the management of diabetes in people (aged 4 and older) with diabetes mellitus when used with the Abbott FreeStyle Libre flash glucose monitoring system sensor. The indication for children (ages 4-17) is limited to those who are supervised by a caregiver who is at least 18 years of age. The caregiver is responsible for managing or assisting the child to manage the LibreLink app and Abbott FreeStyle Libre sensor and also for interpreting or assisting the child to interpret readings from the LibreLink app. It is designed to replace routine fingerprick blood glucose testing except during times of rapidly changing glucose levels or in order to confirm hypoglycaemia or impending hypoglycaemia.
LibreLink and FreeStyle Libre are marks of Abbott Diabetes Care Inc., and are used with permission.